According to Nova one advisor, the global Interventional Radiology Drainage Procedures market was valued at USD 900.4 million in 2021 and it is expected to hit around USD 2.8 billion by 2030 with a CAGR of 4.2% during the forecast period 2022 to 2030.
Interventional radiology drainage is a minimally invasive procedure, which needs a small incision in the skin to guide a flexible catheter to the collection of fluid or air in a drainage bag
This abscess drainage is performed under the supervision of interventional radiologist. A thin needle is placed with the help of imaging guidance (CT, ultrasound, or fluoroscopy) into the abscess to obtain a sample of the infected fluid from an area of the body such as the chest, abdomen, or pelvis.
The global interventional radiology drainage procedures market is driven by rise in prevalence of target diseases, including pelvic inflammatory disease, appendicitis, and bowel obstruction cholecystitis. Increase in demand for less-invasive, and cost-effective modalities boosts market growth.
Rise in patient preference for minimally invasive surgeries fuels the growth of the global interventional radiology drainage procedures market. Demand for minimally invasive surgeries has increased significantly in the past few years. Advantages such as fewer post-surgery complications and side effects, faster recovery, and shorter hospital stay prompt patients to opt for minimally invasive surgeries. According to Ethicon US, LLC, around 9 million minimally invasive procedures were performed in the U.S. in 2013, and the number is likely to increase in the near future.
Minimally invasive procedures utilize advanced technology to reach internal organs through small incisions resulting in less pain, low risk of infection, shorter hospital stay, faster recovery, less scarring, and reduced blood loss compared to traditional surgeries
Report Scope of the Interventional Radiology Drainage Procedures Market
Report Coverage |
Details |
Market Size |
USD 2.8 Billion by 2030 |
Growth Rate |
CAGR of 4.2% from 2022 to 2030 |
Largest Market |
North America |
Fastest Growing Market |
Asia Pacific |
Base Year |
2021 |
Forecast Period |
2022 to 2030 |
Segments Covered |
Type, Application, End User, and Region, |
Companies Mentioned |
|
People Seeking Minimal Invasive Surgeries to Target Injuries Driving Global Demand
Interventional radiology (IR) is a therapeutic specialization that requires performing a range of imaging procedures to capture images of the inside of the body. The interventional radiologist precisely interprets these images to diagnose the found injury or disease and to perform a variety of interventional medical procedures. The radiologist mostly uses imaging procedures such as X-rays, MRI scans, fluoroscopy, CT (computed tomography) scans, and ultrasounds. Interventional radiology drainage procedures include a broad range of procedures such as treating tumors, taking organ biopsies, or placing stents by inserting tiny instruments and thin catheters into the body via an artery or vein. The images are used to oversee catheters and devices to the specific area where the procedure or treatment is to be performed. This procedure reduces the need of open or laparoscopic surgeries, which is primarily driving the global interventional radiology drainage procedures market.
Most people with conditions such as abscess are likely to experience fever, chills, and pain in the approximate body area that is involved. People with these symptoms commonly prefer imaging tests including CT scans or ultrasound to identify and precisely diagnose the abscess. In percutaneous abscess drainage, an interventional radiologist uses imaging tests and guidance to put a thin needle into the abscess and obtain a sample of the infected fluid from the area of the body such as the chest, abdomen, or pelvis. Later, a small drainage catheter is left in place to drain the abscess fluid. Sometimes it might take several days for all the fluid to be completely removed. Seldom, when the abscesses cannot be treated by percutaneous drainage, it may require surgical drainage in the operating room. A rise in patient preference in cost-effective surgeries is expected to propel the demand for the global interventional radiology drainage procedures market.
Increasing Number of New Suppliers Creates New Scope for Easy Equipment Availability
The coronavirus disease 2019 (COVID-19) has created unusual challenges for the healthcare system across the globe. The crisis has evolved rapidly across the world, which resulted in disrupted professional and personal lives, including that of interventional radiology specialists. Moreover, with several industries witnessing a heavy downfall in economy and production, pharmaceutical and healthcare industries have suffered a heavy slowdown due to supply chain restrictions. India and China being major pharmaceutical providers implemented strict regulations to contain the spread of the virus. This resulted in drug shortages worldwide limiting the patients to be safe at home. Furthermore, hospitals expanded their patient capacity, which decreased the amount of appropriate medical imaging that can be safely performed. Radiology experts have experienced the worst economic shock due to restricted imaging availability. In addition, outpatient practices witnessed a heavy impact with decreased interventional radiology drainage procedures.
As the rate of COVID-19 is decreasing due to increased vaccination drives, radiology and diagnostics professionals are focusing on new plans and strategies to be prepared for the increased volume of patients. As there is a slowdown in virus spread, healthcare and radiology practices are allowed to work with the guideless. The interventional radiology drainage procedures market players are designing plans to provide services in remote locations keeping the concept of outdoor lab testing in mind. New players emerging in the near future are most likely to witness mixed reception, while the number of ventures merging and collaborating with other players is expected to increase. The global market is anticipated to increase in the number of new suppliers, which might result in price decline, projecting a moderated interventional radiology drainage procedures market growth in the near future.
Increased Benefits of Minimal Invasive Surgeries Fuel Global Popularity of IR Procedures
Image-guided minimally invasive diagnostic and therapeutic procedures have become an imperative part of interventional radiology drainage procedures. It has considerably decreased the need of invasive practices for sampling deep-seated wounds and treatment of conditions such as abscesses and fluid collections. Some of these procedures may be lifesaving. As the demand for minimally invasive procedures has been increasing due to their advantages over conventional open surgery procedures, the global interventional radiology drainage procedures market is likely to grow exponentially. Moreover, the benefits of minimally invasive practices compared to standard open surgery procedures involve enhanced safety, reduced scarring, quicker recovery, and modified length of hospital stay. Application areas of interventional radiology drainage procedures are also growing due to the rising use of technologically advanced products and techniques, particularly for the treatment of CVD, cancer, and peripheral artery disease (PAD). This is projected to positively impact the growth of the interventional radiology drainage procedures market during the projected period.
The basic interventional radiology drainage procedures include fine-needle aspiration cytology (FNAC), tru-cut (core) biopsy, needle drainage, and percutaneous catheter drainage. In addition, IR procedures involve a mandatory knowledge of hardware, planning, and patient preparation to manage and utilize the products for precise outcomes. The interventional radiology drainage procedures are growing in popularity due to advantages such as fewer post-surgery complexities and side effects, and speedier recovery that prompt patients to adopt minimally invasive surgeries. However, interventional radiology drainage procedures can be expensive. In several developing and underdeveloped regions, especially in South East Asia, governments have not centralized insurance systems and have higher out-of-pocket expenditures. This is likely to be a key restraining factor for the interventional radiology drainage procedures market.
Rising Popularity of IR Procedures Attracts Opportunities in Developing Nations
Currently, North America holds major share of the interventional radiology drainage procedures market. Due to the increasing prevalence of diseases and advanced healthcare infrastructure that enables proper diagnosis and adoption of cost-effective minimally invasive procedures for abscess drainage in the region, North America is expected to dominate the segment during the forecast period. However, in emerging markets such as Brazil, India, and China, the demand is expected in grow in the near future. The Asia Pacific offers lucrative opportunities to the market players, owing to the presence of less stringent regulatory policies and low competition
Market Segmentation: Interventional Radiology Drainage Procedures Market
Regional Overview: Interventional Radiology Drainage Procedures Market
Some of the prominent players in the Interventional Radiology Drainage Procedures Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Interventional Radiology Drainage Procedures market
Type
Application
End User
By Geography
Key Benefits for Stakeholders
Chapter 1. Introduction
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Interventional Radiology Drainage Procedures Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Interventional Radiology Drainage Procedures Market Analysis and Forecast, 2017–2030
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Reimbursement Scenario
5.2. Key Industry Events
5.3. COVID-19 Pandemics Impact on Industry
5.4. Pricing Analysis for Available Products, by Region
5.5. Product Analysis
5.6. List of Manufactures in U.S. and Europe
5.7. Purchase Decision Overview, by Region
6. Global Interventional Radiology Drainage Procedures Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017–2030
6.3.1. Catheter
6.3.1.1. Cholecystectomy Catheter
6.3.1.2. Nephrostomy Drainage Catheter
6.3.1.3. Biliary Drainage Catheter
6.3.1.4. Multipurpose Drainage Catheter
6.3.1.5. Others
6.3.2. Stent
6.3.3. Others
6.4. Market Attractiveness Analysis, by Type
7. Global Interventional Radiology Drainage Procedures Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2030
7.3.1. Abdomen
7.3.2. Pelvis
7.3.3. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Interventional Radiology Drainage Procedures Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2030
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Ambulatory Surgical Centers
8.4. Market Attractiveness Analysis, by End-user
9. Global Interventional Radiology Drainage Procedures Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Interventional Radiology Drainage Procedures Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2017–2030
10.2.1. Catheter
10.2.1.1. Cholecystectomy Catheter
10.2.1.2. Nephrostomy Drainage Catheter
10.2.1.3. Biliary Drainage Catheter
10.2.1.4. Multipurpose Drainage Catheter
10.2.1.5. Others
10.2.2. Stent
10.2.3. Others
10.3. Market Value Forecast, by Application, 2017–2030
10.3.1. Abdomen
10.3.2. Pelvis
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2017–2030
10.4.1. Hospitals
10.4.2. Specialty Clinics
10.4.3. Ambulatory Surgical Centers
10.5. Market Value Forecast, by Country, 2017–2030
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Interventional Radiology Drainage Procedures Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2030
11.2.1. Catheter
11.2.1.1. Cholecystectomy Catheter
11.2.1.2. Nephrostomy Drainage Catheter
11.2.1.3. Biliary Drainage Catheter
11.2.1.4. Multipurpose Drainage Catheter
11.2.1.5. Others
11.2.2. Stent
11.2.3. Others
11.3. Market Value Forecast, by Application, 2017–2030
11.3.1. Abdomen
11.3.2. Pelvis
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2017–2030
11.4.1. Hospitals
11.4.2. Specialty Clinics
11.4.3. Ambulatory Surgical Centers
11.5. Market Value Forecast, by Country/Sub-region, 2017–2030
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Interventional Radiology Drainage Procedures Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2030
12.2.1. Catheter
12.2.1.1. Cholecystectomy Catheter
12.2.1.2. Nephrostomy Drainage Catheter
12.2.1.3. Biliary Drainage Catheter
12.2.1.4. Multipurpose Drainage Catheter
12.2.1.5. Others
12.2.2. Stent
12.2.3. Others
12.3. Market Value Forecast, by Application, 2017–2030
12.3.1. Abdomen
12.3.2. Pelvis
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2017–2030
12.4.1. Hospitals
12.4.2. Specialty Clinics
12.4.3. Ambulatory Surgical Centers
12.5. Market Value Forecast, by Country/Sub-region, 2017–2030
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Interventional Radiology Drainage Procedures Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017–2030
13.2.1. Catheter
13.2.1.1. Cholecystectomy Catheter
13.2.1.2. Nephrostomy Drainage Catheter
13.2.1.3. Biliary Drainage Catheter
13.2.1.4. Multipurpose Drainage Catheter
13.2.1.5. Others
13.2.2. Stent
13.2.3. Others
13.3. Market Value Forecast, by Application, 2017–2030
13.3.1. Abdomen
13.3.2. Pelvis
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2017–2030
13.4.1. Hospitals
13.4.2. Specialty Clinics
13.4.3. Ambulatory Surgical Centers
13.5. Market Value Forecast, by Country/Sub-region, 2017–2030
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Interventional Radiology Drainage Procedures Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017–2030
14.2.1. Catheter
14.2.1.1. Cholecystectomy Catheter
14.2.1.2. Nephrostomy Drainage Catheter
14.2.1.3. Biliary Drainage Catheter
14.2.1.4. Multipurpose Drainage Catheter
14.2.1.5. Others
14.2.2. Stent
14.2.3. Others
14.3. Market Value Forecast, by Application, 2017–2030
14.3.1. Abdomen
14.3.2. Pelvis
14.3.3. Others
14.4. Market Value Forecast, by End-user, 2017–2030
14.4.1. Hospitals
14.4.2. Specialty Clinics
14.4.3. Ambulatory Surgical Centers
14.5. Market Value Forecast, by Country/Sub-region, 2017–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Position Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. AngioDynamics
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Company Financials
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. APR Medtech Ltd
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. Argon Medical Devices, Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Company Financials
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. BD
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Company Financials
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. BIOTEQUE CORPORATION
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Company Financials
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. Boston Scientific Corporation
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Company Financials
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. Cook Medical LLC
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Company Financials
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. Merit Medical Systems
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Company Financials
15.3.8.3. Growth Strategies
15.3.8.4. SWOT Analysis
15.3.9. Optimed
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Company Financials
15.3.9.3. Growth Strategies
15.3.9.4. SWOT Analysis
15.3.10. Rocket Medical plc
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Company Financials
15.3.10.3. Growth Strategies
15.3.10.4. SWOT Analysis
15.3.11. Teleflex Incorporated
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Company Financials
15.3.11.3. Growth Strategies
15.3.11.4. SWOT Analysis
15.3.12. UreSil, LLC
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Company Financials
15.3.12.3. Growth Strategies
15.3.12.4. SWOT Analysis
15.3.13. Other Prominent Players
15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.13.2. Company Financials
15.3.13.3. Growth Strategies
15.3.13.4. SWOT Analysis